Here are four things to know:
1. CollPlant’s products are based on its recombinant human collagen produced with its proprietary plant-based genetic engineering technology.
2. Its flagship rhCollagen BioInk product line is intended for 3D bioprinting, and its Vergenix line of rhCollagen products includes a soft tissue repair matrix for treating tendinopathy as well as a wound repair matrix to promote rapid healing of acute and chronic wounds.
3. The company’s orthobiologic product VergenixSTR is distributed in Europe by Arthrex and is marketed with the Arthrex ACP kit under the ACP Tendo brand.
4. CollPlant recently granted United Therapeutics an exclusive license to its technology for the production and use of rhCollagen-based BioInk for 3D-bioprinted lung transplants.
More articles on biologics:
SpinalCyte’s CybroCell injections led to sustained improvement in clinical study: 5 notes
Researchers use stem cells to create personalized implants with low risk of rejection: 3 things to know
3 things to know about Cellect Biotechnology
